TwoXar, a California-based startup, says it has developed a new platform that can shorten the drug discovery process from years to weeks.
The prospect is so alluring that the company recently raked in $10 million in a series A round of funding led by SoftBank Ventures.
TwoXar says the technology will allow pharmaceutical companies to bypass much of the traditional lab work needed for finding drugs. Instead, the platform merges big data, cloud computing and AI to generate predictive models and more quickly ready new drugs for testing.
Right now, TwoXar says it is particularly focused on disease areas such as diabetes, cancer, dermatology and immunology.
Read the full Business Insider report.